Sandrine Carré-Girard

Equibles does not estimate personal net worth.

Get an email with a short summary when Argenx SE publishes a filing, an earnings call transcript or a press release.

About Sandrine Carré-Girard

Sandrine Carré-Girard has spoken on 1 earnings call across 1 company, most recently for Argenx SE on October 22, 2026. Argenx SE is classified in the Biotechnology industry within the Healthcare sector.

Sandrine Carré-Girard on recent calls

“It has been an incredible quarter with tremendous energy as we engage with HCPs and patients. and the feedback is remarkably consistent. VivGuard continues to set a high bar for what treatment can deliver, and we are seeing the impact it can have for patients.”

Other, Third Quarter 2026 Financial Results and Business Update · October 22, 2026